Vipidia
Vipidia tablets contain Alogliptin, a medication used to improve blood sugar control in adults with type 2 diabetes. As a DPP-4 inhibitor, Alogliptin works by increasing the levels of incretin hormones, which help regulate glucose metabolism. This medication is typically prescribed as part of a comprehensive diabetes management plan, including diet and exercise. Vipidia helps in reducing blood sugar levels by enhancing the body's own ability to control glucose. It's available in tablet form for convenient oral administration. Regular monitoring of blood sugar levels is recommended to ensure effective management of diabetes. Vipidia is often used when other medications have not provided adequate glycemic control.Active substance:
AlogliptinPharmachologic effect:
Alogliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that works by increasing the levels of incretin hormones, which increase insulin release and decrease glucagon levels in the circulation in a glucose-dependent manner.Indications:
- Type 2 diabetes mellitus to improve glycemic control in adults as an adjunct to diet and exercise.
Contraindications:
- Hypersensitivity to alogliptin or any of the excipients
- Severe renal impairment
- End-stage renal disease
- Diabetic ketoacidosis
- Type 1 diabetes mellitus
Side effects:
In order of decreasing probability: Headache, Nasopharyngitis, Upper respiratory tract infection, Hypoglycemia, Pancreatitis, Allergic reactions
Dosing and Administration:
The recommended dose of Vipidia is 25 mg once daily, taken with or without food. Adjustments in dosing may be required based on renal function.
Storage:
Store at a temperature not exceeding 25°C (77°F).
Vipidia
in Cyrillic : Випидия
SUBSTANCE
Alogliptin
DOSAGE FORM
tablets
